Skip to Content

Proposed Rule

Oral Health Care Drug Products for Over-the-Counter Human Use; Antigingivitis/Antiplaque Drug Products; Establishment of a Monograph; Extension of Comment Period; Correction

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Advance notice of proposed rulemaking; extension of comment period; correction.

SUMMARY:

The Food and Drug Administration (FDA) is correcting a document that appeared in the Federal Register of August 25, 2003 (68 FR 50991). The document announced that FDA extended to November 25, 2003, the comment period for an advance notice of proposed rulemaking (ANPR) for over-the-counter antigingivitis/antiplaque drug products. The ANPR was published in the Federal Register of May 29, 2003 (68 FR 32232). The document published with an inadvertent error. This document corrects that error.

DATES:

Submit written or electronic comments by November 25, 2003. Submit reply comments by February 23, 2004.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Joyce Strong, Office of Policy and Planning (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In FR Doc. 03-21669, appearing on page 50992 in the Federal Register of August 25, 2003, the following correction is made:

1. On page 50992, in the second column, under IV. Comments, in the sixth line, “two” is corrected to read “three”.

Start Signature

Dated: September 25, 2003.

Jeffrey Shuren,

Assistant Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 03-25044 Filed 10-3-03; 8:45 am]

BILLING CODE 4160-01-S